1. An immunologically relevant rodent model demonstrates safety of therapy using a tumour‐specific IgE. Issue 12 (8th October 2018) Authors: Josephs, D. H.; Nakamura, M.; Bax, H. J.; Dodev, T. S.; Muirhead, G.; Saul, L.; Karagiannis, P.; Ilieva, K. M.; Crescioli, S.; Gazinska, P.; Woodman, N.; Lombardelli, C.; Kareemaghay, S.; Selkirk, C.; Lentfer, H.; Barton, C.; Canevari, S.; Figini, M.; Downes, N.; Dombrowicz, D. Journal: Allergy Issue: Volume 73:Issue 12(2018) Page Start: 2328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of allergen‐dependent IgE activity by antibodies of the same specificity but different class. Issue 6 (28th March 2015) Authors: Dodev, T. S.; Bowen, H.; Shamji, M. H.; Bax, H. J.; Beavil, A. J.; McDonnell, J. M.; Durham, S. R.; Sutton, B. J.; Gould, H. J.; James, L. K. Journal: Allergy Issue: Volume 70:Issue 6(2015:Jun.) Page Start: 720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗